About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Ohio | 987 Studies

Clinical Trials Breast CancerOhio

Breast Cancer Clinical Trials in Ohio

Find 987 clinical trials for breast cancer near Ohio. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Ohio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 961-980 of 987 trials

CompletedComparison of First Sense Breast Exam® to the University of Toledo Mammography and Biopsy ResultsFirst Sense Medical®, LLC is a medical device company developing a novel breast cancer screening tester called the First Sense Breast Exam® Tester.NCT02633605·Toledo, Ohio CompletedTrial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast CancerThis randomized, double blind, placebo controlled trial will evaluate the impact of adding everolimus to the combination of weekly paclitaxel plus bevacizumab in the first-line…NCT00915603·LaVerne, California and 14 others Active not recruitingVeliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast CancerThis phase I trial studies the side effects and best dose of veliparib when given together with carboplatin and to see how well they work in treating patients with human epidermal…NCT01251874·The Bronx, New York and 2 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedLEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)The purpose of this signal seeking study was to determine whether treatment with LEE011 demonstrates sufficient efficacy in CDK4/6 pathway activated solid tumors and/or…NCT02187783·Birmingham, Alabama and 60 others

CompletedA Sleep Intervention to Improve Outcomes Among Women at High Risk of Breast CancerParticipants are asked to participate in a research study of the effect of a sleep intervention on improving sleep habits and reducing their risk of breast cancer.NCT02613923·Cleveland, Ohio

CompletedStudy of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast CancerRATIONALE: Measuring levels of calgranulin A and calgranulin B in the blood of patients with breast cancer in the laboratory may help doctors identify and learn more about…NCT00900133·Cleveland, Ohio

Active not recruitingA Patient Navigation Intervention for the Improvement of Risk Management Among Women at High Risk of Breast CancerThis clinical trial studies whether a patient navigation (PN) intervention can be used to improve risk management among women at high risk of breast cancer.NCT06950008·Columbus, Ohio

Active not recruitingTolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast CancerThis phase II trial studies the side effects and how well lapatinib ditosylate and trastuzumab work in treating older patients with human epidermal growth factor receptor 2…NCT01273610·Duarte, California and 7 others

CompletedA Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast CancerThis study was a Phase III, randomized, double-blind, placebo-controlled, multicenter international clinical trial conducted to investigate the use of pertuzumab in combination…NCT00567190·Scottsdale, Arizona and 321 others

CompletedA Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast CancerThis study is being done for the following reasons: * The study has two parts.NCT02236000·Weston, Florida and 14 others

RecruitingTeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer PatientsThis research is being done to assess whether an exercise intervention with protein intake support vs a health education and support program will make it easier for women age 65…NCT05535192·Boston, Massachusetts and 3 others

WithdrawnAllogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00006261·Cleveland, Ohio

CompletedPalbociclib in Real World PracticeThis Non-Interventional Study will describe and analyze the clinical use of palbociclib in routine clinical practice in the treatment of advanced breast cancer.NCT03280303·Alabaster, Alabama and 304 others

CompletedDocetaxel Plus Imatinib Mesylate in Metastatic Breast CancerThis trial evaluates the novel combination of docetaxel with imatinib as first or second line therapy in advanced breast cancer with the aim of achieving higher effectiveness and…NCT00193180·Gainesville, Georgia and 5 others

Active not recruitingComparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving ImmunotherapyThis study is designed to see if we can lower the chance of side effects from radiation in patients with breast, kidney, small cell lung cancer, non-small cell lung cancer or…NCT05703269·Savannah, Georgia and 33 others

Active not recruitingTesting the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast CancerThis phase Ib trial studies the best dose of berzosertib when given together with the usual treatment (radiation therapy) in treating patients with triple negative or estrogen…NCT04052555·Phoenix, Arizona and 13 others

CompletedProphylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast CancerThis randomized pilot phase II trial studies and compares prophylactic topical agents in reducing radiation-induced dermatitis in patients with non-inflammatory breast cancer or…NCT02556632·Newark, Delaware and 5 others

RecruitingA Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast CancerThe purpose of this study is to assess the safety of GDC-4198 alone and in combination with giredestrant and also the efficacy of GDC-4198 + giredestrant versus abemaciclib +…NCT07100106·Huntsville, Alabama and 76 others

CompletedHealth Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer SurvivorsThis clinical trial evaluates the feasibility of coaching-based navigation for black breast cancer survivors including recruitment, dropout, and survey completion rates.NCT05674578·Columbus, Ohio

UnknownEstablishing the Recommended Biological Dose for AE37 Peptide Vaccine in Combination With Pembrolizumab That Will Enhance the Tumor-specific Immune Response and Demonstrate Efficacy in Patients With Advanced Triple-negative Breast CancerThis study will look to establish the recommended biologic dose of AE37 in combination with pembrolizumab that will enhance the tumor-specific immune response and demonstrate…NCT04024800·Decatur, Illinois and 5 others

PreviousPage 49 of 50Next

Other Conditions in Ohio

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma